2/27/15 Dr Thomas Wang in his lab, Associate Professor of Internal Medicine; Biomedical Engineering and of Mechanical Engineering.

With $1.55 billion in annual research expenditures, the University of Michigan ranks first in research volume among all U.S. public universities. The university’s ongoing commercialization efforts help transfer innovative research from the lab to the marketplace, thus improving lives and driving economic growth through the development of new products and services.

  • The Medical School’s Fast Forward Medical Innovation (FFMI) provides a front door for the campus community and industry partners to access and navigate the university’s rich biomedical innovation ecosystem. The team at FFMI has developed unique and integrative programs that help U-M researchers accelerate and transition their discoveries onto viable commercialization paths.
  • U-M Tech Transfer, a unit of the Office of Research, is responsible for the commercialization of university research discoveries. The team at Tech Transfer enhances these research discoveries to encourage licensing and broad deployment with existing businesses and new U-M startups. U-M Tech Transfer has earned a reputation for performance among the top 10 of all universities.
  • The Business Engagement Center (BEC), a unit of the Office of Research and Office of University Development, is industry’s front door to U-M. The BEC inspires successful collaboration and acts as a catalyst to create meaningful, invaluable partnerships by connecting U-M researchers with industry.

These are just three examples of how U-M fosters innovation and commercializes university research for greater societal impact.

“The breadth and depth of research here at the University of Michigan leads to new discoveries that advance industries, create jobs and drive our state’s global competitiveness,” says U-M President Mark Schlissel.